ESGO Accreditation & Certifications

For Training in Gynaecological Oncology
and Ovarian Cancer Surgery Certifications

Get Your Professional Subspecialty Accreditation

Interested in advancing your professional training in gynaecological oncology?

Check out the list of European Accredited Centres in Gynaecological Oncology by ESGO that are authorised to provide accredited training to fellow trainees (up to a confirmed number of trainees).

Application Process
Application Process

Are you a Trainee interested in the accredited European subspecialty training?

  • Review the General rules of ESGO certification of trainees.
  • Directly contact ESGO certified training centres to apply for a local fellowship position.
  • Accepted? Fill in the online application form in MyESGO section.
  • Fulfill the training programme according to the new ESGO Curriculum.
  • Before the start of their training, the fellow must submit the eLogBook Application form via MyESGO section.
  • Ready to apply?
    The following documents will be required during the application process:

    • your profile photo
    • CV
    • Certificate of medical degree
    • Ob/gyn specialist certificate
    • Colonoscopy course - certificate (optional)
    • Training programme plan
eLOG Book
International Trainees Trained in UK & NL
tab

Summary of rules for individual certification

Started your training programme? Fill out online the  e-LOG Book for every step you have accomplished!

All your assessments and improvements will be easily recorded!

Be in compliance with the new ESGO Curriculum which can be downloaded HERE

Note that:

  • The training includes a minimum of two (2) and at the most three (3) clinical years of full-time equivalent (FTE) training according to a prospectively approved programme in an ESGO-accredited Gynaecological Oncology unit.
  • Fellows in their 1st year of a 2 year programme or in their 1st or 2nd year of a 3 year programme need to switch immediately to the new curriculum
  • Fellows in their last year may choose to switch to the new curriculum and online portfolio or continue with the past requirements of the old curriculum.
  • Successful completion of the curriculum and a passing mark on the ESGO theoretical Exam are mandatory requirements for obtaining the ESGO certification. The ESGO Exam must be passed within six (6) years from the formal start of training.
  • Modules of another specialty (e.g., radiotherapy, medical oncology, surgery) may be followed for up to six (6) months within the fellowship programme.

The portfolio must be completed within four (4) years after the formal start of training. Retrospective fulfilment of the criteria, e.g., completion of the portfolio over years of oncological practice without a registered and defined training programme, is not allowed.

For any further information about the new Curriculum and/or the certification please feel free to contact the ESGO office

Need further information? Contact the ESGO Administrative Office.

Trainees awarded the ESGO Diploma of European Gynaecological Oncologist in 2018-2021

 

2021

  • Rosa María Montero Macías, MD

trained in the Service de Chirurgie Cancérologique Gynécologique, Georges Pompidou European Hospital, Paris, France

 

  • Beatriz Navarro Santana, MD

trained in the Department of Gynaecological Oncology, Institut Bergonie, Bordeaux, France

 

  • Ilaria Betella, MD

trained in Department of Gynaecologic Oncology, European Institute of Oncology (IEO), Milan, Italy

 

  • Aemn Ismail, MD

trained in Department of Obstetrics & Gynaecology, University Hospitals of Leicester NHS Trust, UK

 

  • Sergi Fernandez-Gonzalez, MD

trained in Department of Gynaecology, Medical Oncology and Radiotherapy, University Hospital of Bellvitge, University of Barcelona

 

  • Thijs Roelofsen, MD

Trained at the Department of Obstetrics & Gynecology, University Medical Center Groningen, The Netherlands

 

  • Stamatios Petousis, MD

Ippokration General Hospital, 2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece

 

  • Mohamed Otify, MD

St James’s Hospital, Institute of Oncology, Leeds Teaching Hospitals NHS Trust

 

  • Charalampos Theofanakis, MD

University of Athens/ Alexandra Hospital, Department of Gynaecologic Oncology, Athens, Greece

 

  • James Patrick Beirne, MD

Northern Ireland Gynaecological Cancer Centre, Belfast City Hospital, UK, Northern Ireland, Belfast

 

  • Duygu Guzel, MD

Gynecologic Oncology Department, Ege University, Faculty of Medicine, Izmir, Turkey

 

  • Vicente Bebia, MD

Gynaecologic Oncology Unit, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

 

  • Merethe Ravlo, MD

Department of Gynaecological Cancer, St. Olavs hospital, Trondheim, Norway

 

  • Valentina Ghirardi, MD

Policlinico Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

 

  • Nicolo Bizzarri,  MD 

Policlinico Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

 

  • Paul Stanciu,  MD 

The Royal Marsden Hospital,Department of Gynaecological Oncology, London, United Kingdom

 

  • Sileny Han,  MD 

Trained at the University Hospitals, Department of Gynaecological Oncology, Leuven, Brussels

 

  • Seda Şahin Aker,  MD 

Trained at the Ankara University Hospital, Department of Gynaecologic Oncology, Ankara, Turkey

 

  • Salih Taskin, MD,  MD 

Trained at the Ankara University School of Medicine, Department of Gynaecological Oncology, Ankara, Turkey

 

  • Mai Partridge Jensen,  MD 

Trained at the Odense University Hospital, Department Gynaecology and Obstetrics, Denmark

 

2020

  • Tine Henrichsen Schnack,  MD 

Trained at the Coppenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

 

  • İlker Çakır,  MD 

Trained at the University of Health Sciences Tepecik Education and Research Hospital, Department of Gynecologic Oncology, Izmir, Turkey

 

  • Volkan Karataşlı,  MD 

Trained at the University of Health Sciences Tepecik Education and Research Hospital, Department of Gynecologic Oncology, Izmir, Turkey

 

  • Behzat CAN,  MD 

Trained at the University of Health Sciences Tepecik Education and Research Hospital, Department of Gynecologic Oncology, Izmir, Turkey

 

  • Martina Aida ANGELES FITE, MD

Trained at the Department of of Surgical Oncology, Institut Universitaire du Cancer de Toulouse – Oncopole, France

 

  • Ariel Gustavo GLICKMAN, MD 

Trained at the GYNECOLOGIC ONCOLOGY UNIT, BARCELONA CLÍNIC HOSPITAL

 

  • Claire THOMPSON, MD 

Trained at the Department of Gynaecological Oncology, St James’s Hospital, Dublin, Ireland

 

  • Ibon JAUNARENA MARIN, MD 

Trained at the Department of Obstetrics & Gynecology, Donostia University Hospital, Donostia, Spain

 

  • Olesya SOLHEIM, MD

Trained at the Department of Gynaecological Oncology, the Norwegian Radiumhospital, Oslo University Hospital

 

  • Natascha de LANGE, MD

Trained at the Department of Gynaecological Oncology, University Medical Centre Groningen, The Netherlands

 

  • Agnieszka RYCHLIK, MD

Trained at the the Institut Bergonie, Department of Surgery, Bordeaux, France

 

  • Henrica Maria Johanna WERNER, MD

Trained at the Department of Gynaecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

 

2019

  • Cihan COMBA, MD

Trained at the Bakirkoy Dr. Sadi Konuk Training and Research Hospital University of Health Sciences, Istanbul, Turkey

  • Emmanouil KALAMPOKAS, MD

Trained at the NHS Grampian, Aberdeen Royal Infirmary, Department of training Gynaecological Oncology, UK

  •  Orhan TEMEL, MD

Trained at the Tepecik Education and Research Hospital, Department of Gynaecological Oncology, Izmir, Turkey

  •  Katja DAHL, MD

Trained at the Department for Gynaecology and Obstetrics, Aarhus University Hospital, Skejby, Denmark

  •  Judith Susanne LAFLEUR,  MD

Trained at the Department of  Gynaecology,  St. Vincent´s Hospital, Linz, Austria

  •  Fabio MARTINELLI,  MD

Trained at the Department of Gynaecologic Oncology, the IRCCS Foundation - National Cancer Institute, Milan, Italy

  • Katrine FUGLSANG,  MD

Trained at the Department of Gynaecology and Obstetrics, Aarhus University Hospital, Denmark

  • Carlos Martínez Gómez, MD

Trained at the  Institut Universitaire de Cancer de Toulouse-Institut Claudius Regaud, Department of Surgical Oncology, Toulouse, France

  • Corine KOOPMANS, MD

Trained at the University Medical Center Groningen
Department of Obsterics and Gynecology, Groningen, The Netherlands

  • Víctor Lago Leal, MD  

Trained at the Hospital Universitario y Politécnico La Fe
Department of Gynaecologic Oncology, Valencia, Spain

  • Alessia ALOISI, MD

Trained at the  Department of Surgery, Memorial Sloan Kettering Cancer Centre, Department of Surgery, New York, USA

  • Oguzhan KURU, MD

Trained at the Hacettepe University Adult Hospital, Department of Gynaecological Oncology, Ankara, Turkey

  • Silvia Cabrera DÍAZ, MD

Trained at the  Hospital Universitari Vall d’Hebron, Department of Gynaecologic Oncology, Barcelona, Spain

  • Antonios Anagnostopoulos, MD

Trained at the Trained at the Northwest Coast Gynaecological Oncology Network/Liverpool Women’s Hospital – Royal Preston Hospital, Department of Gynaecological Oncology, UK

  • Christos IAVAZZO, MD

Trained at the Gynaecological Oncology Department, the Christie Hospital, Manchester, UK and Gynaecological Oncology Department, Royal Surrey County Hospital, Guildford, UK

 

2018

  • Kartika HAPSARI, MD

Trained at the  UMC Utrecht, The Netherland, Department of Obstetrics and Gynaecology

  • Mkrtchyan Haik BAGRAT, MD

Trained at the  National Medical Research Center of Oncology named after N.N.Petrov, Department of Gynaecological Oncology, Russian Federation, Saint-PetersburgDepartment of Surgery, Memorial Sloan Kettering Cancer Centre, New York, USA

  • Ilker KAHRAMANOGLU, MD

Trained at the  Istanbul University, Cerrahpasa School of Medicine,
Department of Obstetrics and Gynaecology, Istanbul, Turkey